Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Oct 24 2022 | How Caregivers Play an Important Role in the Diagnosis of ATTR-CM Patient News Heart Failure Awareness 365 Patient Resource Read More Oct 16 2022 | HFSA President's Update: October 2022 HFSA News President's Updates Read More Oct 12 2022 | HFSA Career Center Drawing HFSA News Membership Professional Development Read More Oct 11 2022 | scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure Industry News Industry Read More Oct 1 2022 | HFSA Collaborates with the Foundation for the National Institutes of Health (FNIH) and the National Heart, Lung, and Blood Institute (NHLBI) on the launch of the new Accelerating Medicines Partnership® Heart Failure (AMP® HF) Program Practice News In The News Press Release Read More Pagination First page « First Previous page ‹ Previous … Page 31 Page 32 Page 33 Page 34 Current page 35 Page 36 Page 37 Page 38 Page 39 … Next page Next › Last page Last »
Oct 24 2022 | How Caregivers Play an Important Role in the Diagnosis of ATTR-CM Patient News Heart Failure Awareness 365 Patient Resource Read More
Oct 11 2022 | scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure Industry News Industry Read More
Oct 1 2022 | HFSA Collaborates with the Foundation for the National Institutes of Health (FNIH) and the National Heart, Lung, and Blood Institute (NHLBI) on the launch of the new Accelerating Medicines Partnership® Heart Failure (AMP® HF) Program Practice News In The News Press Release Read More
